• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去氨加压素和酚磺乙胺对各种遗传性出血性疾病患者出血时间的协同缩短作用。

Synergistic shortening of the bleeding time by desmopressin and ethamsylate in patients with various constitutional bleeding disorders.

作者信息

Kobrinsky N L, Israels E D, Bickis M G

机构信息

Department of Pediatrics and Child Health, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.

出版信息

Am J Pediatr Hematol Oncol. 1991 Winter;13(4):437-41. doi: 10.1097/00043426-199124000-00008.

DOI:10.1097/00043426-199124000-00008
PMID:1785670
Abstract

Desmopressin and ethamsylate were evaluated for possible synergistic effects on the bleeding time. The drugs were administered individually and together to 12 patients with markedly prolonged bleeding times known to be relatively or absolutely unresponsive to desmopressin alone. The bleeding disorders studied included Glanzmann's thrombasthenia (one), other disorders of platelet function (four), pseudo-von Willebrand disease (one), and von Willebrand disease type I (three), type II (two), and type III (one). Desmopressin alone shortened the bleeding time from 23.9 +/- 1.5 to 19.5 +/- 2.3 min (p = 0.03). Ethamsylate alone was without effect. Desmopressin and ethamsylate together shortened the bleeding time to 11.2 +/- 1.4 min (p less than 0.01 compared to baseline, p = 0.02 compared to desmopressin alone). The combination was ineffective in three patients, with Glanzmann's thrombasthenia (one), and von Willebrand disease type I (one) and type III (one). Toxic effects of the drugs were not observed. Five patients received desmopressin and ethamsylate prior to dental work with mandibular block (one), heart surgery requiring cardiopulmonary bypass (two), and adenotonsillectomy surgery (two). Normal hemostasis was achieved in each case. A synergistic shortening of the bleeding time was observed with the combination of desmopressin and ethamsylate in a wide range of bleeding disorders.

摘要

评估了去氨加压素和酚磺乙胺对出血时间可能的协同作用。将这些药物单独及联合给予12例出血时间明显延长的患者,已知这些患者对单独使用去氨加压素相对或绝对无反应。所研究的出血性疾病包括Glanzmann血小板无力症(1例)、其他血小板功能障碍(4例)、假性血管性血友病(1例)以及血管性血友病I型(3例)、II型(2例)和III型(1例)。单独使用去氨加压素可使出血时间从23.9±1.5分钟缩短至19.5±2.3分钟(p = 0.03)。单独使用酚磺乙胺则无效果。去氨加压素和酚磺乙胺联合使用可使出血时间缩短至11.2±1.4分钟(与基线相比p<0.01,与单独使用去氨加压素相比p = 0.02)。该联合用药对3例患者无效,包括Glanzmann血小板无力症(1例)、血管性血友病I型(1例)和III型(1例)。未观察到药物的毒性作用。5例患者在进行下颌阻滞牙科手术(1例)、需要体外循环的心脏手术(2例)和腺样体扁桃体切除术(2例)之前接受了去氨加压素和酚磺乙胺治疗。在每种情况下均实现了正常止血。在多种出血性疾病中,观察到去氨加压素和酚磺乙胺联合使用可协同缩短出血时间。

相似文献

1
Synergistic shortening of the bleeding time by desmopressin and ethamsylate in patients with various constitutional bleeding disorders.去氨加压素和酚磺乙胺对各种遗传性出血性疾病患者出血时间的协同缩短作用。
Am J Pediatr Hematol Oncol. 1991 Winter;13(4):437-41. doi: 10.1097/00043426-199124000-00008.
2
Use of DDAVP in inherited and acquired platelet dysfunction.去氨加压素在遗传性和获得性血小板功能障碍中的应用。
Am J Hematol. 1990 Jan;33(1):39-45. doi: 10.1002/ajh.2830330108.
3
Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: reduction in blood product usage with desmopressin.
J Am Coll Cardiol. 1987 May;9(5):1139-47. doi: 10.1016/s0735-1097(87)80319-4.
4
Shortening of bleeding time by 1-deamino-8-D-arginine vasopressin in various bleeding disorders.1-去氨基-8-D-精氨酸血管加压素对各种出血性疾病出血时间的缩短作用。
Lancet. 1984 May 26;1(8387):1145-8. doi: 10.1016/s0140-6736(84)91393-x.
5
The use of desmopressin in open-heart surgery.去氨加压素在心脏直视手术中的应用。
Haemophilia. 2008 Jan;14 Suppl 1:40-7. doi: 10.1111/j.1365-2516.2007.01608.x.
6
Desmopressin (DDAVP) for treatment of disorders of hemostasis.去氨加压素(DDAVP)用于治疗止血障碍。
Prog Hemost Thromb. 1986;8:19-45.
7
Recombinant activated factor VII combined with desmopressin in preventing bleeding from dental extraction in a patient with Glanzmann's thrombasthenia.重组活化因子VII联合去氨加压素预防Glanzmann血小板无力症患者拔牙后出血
Clin Appl Thromb Hemost. 2006 Jan;12(1):115-6. doi: 10.1177/107602960601200120.
8
Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyser at high shear rates.血管性血友病的治疗监测:高剪切率下血小板功能分析仪的作用及局限性
Br J Haematol. 1999 Sep;106(3):777-83. doi: 10.1046/j.1365-2141.1999.01604.x.
9
A study of the effect of ethamsylate (Dicynene) on the bleeding time, von Willebrand factor level and fibrinolysis in patients with von Willebrand's disease.一项关于酚磺乙胺(止血敏)对血管性血友病患者出血时间、血管性血友病因子水平及纤维蛋白溶解作用的研究。
Thromb Haemost. 1988 Dec 22;60(3):506-7.
10
Shortening of bleeding time by 1-deamino-8-arginine vasopressin (DDAVP) in the absence of platelet von Willebrand factor in Gray platelet syndrome.在灰色血小板综合征中,缺乏血小板血管性血友病因子时1-去氨基-8-精氨酸加压素(DDAVP)对出血时间的缩短作用。
Thromb Haemost. 1987 Dec 18;58(4):1060-3.

引用本文的文献

1
Dental Management of Seven-Year-Old Child With Glanzmann Thrombasthenia: A Case Report.患有Glanzmann血小板无力症的七岁儿童的牙科管理:一例报告
Cureus. 2024 Sep 26;16(9):e70243. doi: 10.7759/cureus.70243. eCollection 2024 Sep.